491 related articles for article (PubMed ID: 22526860)
1. [Clinical and health economic challenges of personalized medicine].
Brüggenjürgen B; Kornbluth L; Ferrara JV; Willich SN
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 May; 55(5):710-4. PubMed ID: 22526860
[TBL] [Abstract][Full Text] [Related]
2. [Health economic evaluation based on administrative data from German health insurance].
Schreyögg J; Stargardt T
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 May; 55(5):668-74. PubMed ID: 22526855
[TBL] [Abstract][Full Text] [Related]
3. [Implicit versus explicit rationing of health services].
Breyer F
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 May; 55(5):652-9. PubMed ID: 22526853
[TBL] [Abstract][Full Text] [Related]
4. [Decision support through economic evaluation from the perspective of science in Germany].
Graf von der Schulenburg JM
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 May; 55(5):660-7. PubMed ID: 22526854
[TBL] [Abstract][Full Text] [Related]
5. [Effects of multimorbidity on health care utilization and costs].
Lehnert T; König HH
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 May; 55(5):685-92. PubMed ID: 22526857
[TBL] [Abstract][Full Text] [Related]
6. [Aspects of health economic evaluations as a contribution to the priority-setting debate in Germany].
Brüggenjürgen B
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Sep; 53(9):890-5. PubMed ID: 20853085
[TBL] [Abstract][Full Text] [Related]
7. Challenges for the German Health Care System.
Dietrich CF; Riemer-Hommel P
Z Gastroenterol; 2012 Jun; 50(6):557-72. PubMed ID: 22660990
[TBL] [Abstract][Full Text] [Related]
8. Critical Care and Personalized or Precision Medicine: Who needs whom?
Sugeir S; Naylor S
J Crit Care; 2018 Feb; 43():401-405. PubMed ID: 29174462
[TBL] [Abstract][Full Text] [Related]
9. Decision making in Germany: is health economic evaluation as a supporting tool a sleeping beauty?
Gerber-Grote A; Sandmann FG; Zhou M; Ten Thoren C; Schwalm A; Weigel C; Balg C; Mensch A; Mostardt S; Seidl A; Lhachimi SK
Z Evid Fortbild Qual Gesundhwes; 2014; 108(7):390-6. PubMed ID: 25444297
[TBL] [Abstract][Full Text] [Related]
10. Processes of psoriasis health care in Germany--long-term analysis of data from the statutory health insurances.
Augustin M; Glaeske G; Schäfer I; Rustenbach SJ; Hoer A; Radtke MA
J Dtsch Dermatol Ges; 2012 Sep; 10(9):648-55. PubMed ID: 22525221
[TBL] [Abstract][Full Text] [Related]
11. [Economic limits in intensive care. Can we still afford intensive care in the year 2000?].
Barckow D
Z Arztl Fortbild Qualitatssich; 2000 Dec; 94(10):828-33; discussion 845. PubMed ID: 11190918
[TBL] [Abstract][Full Text] [Related]
12. [Budget problems in rehabilitation].
Buschmann-Steinhage R
Rehabilitation (Stuttg); 2012 Apr; 51(2):81-8. PubMed ID: 22570154
[TBL] [Abstract][Full Text] [Related]
13. Economic viability of Stratified Medicine concepts: An investor perspective on drivers and conditions that favour using Stratified Medicine approaches in a cost-contained healthcare environment.
Fugel HJ; Nuijten M; Postma M
N Biotechnol; 2016 Dec; 33(6):860-867. PubMed ID: 27664792
[TBL] [Abstract][Full Text] [Related]
14. Strategies to overcome clinical, regulatory, and financial challenges in the implementation of personalized medicine.
Tsimberidou AM; Ringborg U; Schilsky RL
Am Soc Clin Oncol Educ Book; 2013; ():118-25. PubMed ID: 23714475
[TBL] [Abstract][Full Text] [Related]
15. What is the contribution of health economic evaluations to decision-making in health care? Experiences from 7 selected countries.
Gerber-Grote A; Windeler J
Z Evid Fortbild Qual Gesundhwes; 2014; 108(7):358-9, 355-7. PubMed ID: 25444292
[No Abstract] [Full Text] [Related]
16. Health technology assessment and personalized medicine: are economic evaluation guidelines sufficient to support decision making?
Husereau D; Marshall DA; Levy AR; Peacock S; Hoch JS
Int J Technol Assess Health Care; 2014 Apr; 30(2):179-87. PubMed ID: 24806420
[TBL] [Abstract][Full Text] [Related]
17. [Rationing in German health care with particular consideration of oncology: view points of German stakeholders--a qualitative interview study].
Lange J; Gönner C; Vollmann J; Rauprich O
Gesundheitswesen; 2015 Jan; 77(1):8-15. PubMed ID: 24696371
[TBL] [Abstract][Full Text] [Related]
18. [Do you reflect before every treatment: what is this patient worth to society?].
Wiedemann B
MMW Fortschr Med; 2002 Dec; 144(50):58. PubMed ID: 14610869
[No Abstract] [Full Text] [Related]
19. A systematic review and checklist presenting the main challenges for health economic modeling in personalized medicine: towards implementing patient-level models.
Degeling K; Koffijberg H; IJzerman MJ
Expert Rev Pharmacoecon Outcomes Res; 2017 Feb; 17(1):17-25. PubMed ID: 27978765
[TBL] [Abstract][Full Text] [Related]
20. [Challenges of an integrative and personalised health care for health economics and the insurance system].
Schoch GG; Würdemann E
Gesundheitswesen; 2014 Nov; 76(11):e69-73. PubMed ID: 25321864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
